Lv11
40 积分 2024-04-10 加入
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
1小时前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
2天前
已完结
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
3天前
已完结
Alirocumab plus cemiplimab in advanced immuno-refractory metastatic non-small cell lung cancer: an ongoing multi-center phase II study
4天前
已完结
The next generation of immunotherapies for lung cancers
6天前
已完结
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial
1个月前
已完结
A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study
1个月前
已完结
Efficacy and Safety of Spleen Tyrosine Kinase and VEGFR-2 Dual-Target Kinase Inhibitor (OT202) in Dry Eye
2个月前
已完结
The JRS guideline for the management of pneumonia in adults 2024
2个月前
已完结
Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases
2个月前
已完结
皖公网安备34019202002308
